JEPQ vs. FMED

Last updated Jun 16, 2026

JEPQ (JPMorgan Nasdaq Equity Premium Income ETF) and FMED (Fidelity Disruptive Medicine ETF) are both exchange-traded funds - JEPQ is a Nasdaq-100 fund tracking the Nasdaq-100 Index, while FMED is a Health & Biotech Equities fund actively managed by Fidelity. JEPQ is passively managed, while FMED is actively managed. Over the past 3 years, JEPQ returned 20.72%/yr vs 0.73%/yr for FMED. A 0.53 correlation means they provide meaningful diversification when combined. JEPQ charges 0.35%/yr vs 0.50%/yr for FMED.

Performance

JEPQ vs. FMED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) and Fidelity Disruptive Medicine ETF (FMED). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, JEPQ achieves a 10.23% return, which is significantly higher than FMED's -4.75% return.

JEPQ

• 1D: 2.21%
• 1M: 3.31%
• YTD: 10.23%
• 6M: 11.56%
• 1Y: 29.39%
• 3Y*: 20.72%
• 5Y*: —
• 10Y*: —

FMED

• 1D: 0.90%
• 1M: 7.10%
• YTD: -4.75%
• 6M: -6.17%
• 1Y: 8.53%
• 3Y*: 0.73%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

JEPQ vs. FMED - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
JEPQ JPMorgan Nasdaq Equity Premium Income ETF	10.23%	15.18%	24.85%	11.97%
FMED Fidelity Disruptive Medicine ETF	-4.75%	9.69%	2.29%	-3.59%

Correlation

The correlation between JEPQ and FMED is 0.49, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.49
Correlation (3Y) Calculated over the trailing 3-year period	0.53
Correlation (All Time) Calculated using the full available price history since Jun 12, 2023	0.53

The correlation between JEPQ and FMED has been stable across timeframes, ranging from 0.49 to 0.53 - a consistent structural relationship.

JEPQ vs. FMED - Sectors Allocation Comparison

Sectors	JEPQ	FMED
Technology	58.9%	0.9%
Communication Services	13.9%	-
Consumer Cyclical	11.8%	-
Consumer Defensive	6.0%	-
Healthcare	3.9%	97.1%
Industrials	2.8%	-
Utilities	1.1%	-
Basic Materials	0.9%	-
Financial Services	0.3%	-
Energy	0.3%	-
Real Estate	0.2%	-

Return for Risk

JEPQ vs. FMED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JEPQ

JEPQ Risk / Return Rank: 81
JEPQ Sharpe Ratio Rank: 81
JEPQ Sortino Ratio Rank: 77
JEPQ Omega Ratio Rank: 85
JEPQ Calmar Ratio Rank: 73
JEPQ Martin Ratio Rank: 86

FMED

FMED Risk / Return Rank: 15
FMED Sharpe Ratio Rank: 16
FMED Sortino Ratio Rank: 16
FMED Omega Ratio Rank: 15
FMED Calmar Ratio Rank: 14
FMED Martin Ratio Rank: 14

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JEPQ vs. FMED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) and Fidelity Disruptive Medicine ETF (FMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	JEPQ	FMED	Difference
Sharpe ratio: Return per unit of total volatility	2.31	0.44	+1.87
Sortino ratio: Return per unit of downside risk	3.06	0.79	+2.26
Omega ratio: Gain probability vs. loss probability	1.46	1.09	+0.37
Calmar ratio: Return relative to maximum drawdown	3.35	0.47	+2.88
Martin ratio: Return relative to average drawdown	15.94	1.03	+14.90

JEPQ vs. FMED - Sharpe Ratio Comparison

The current JEPQ Sharpe Ratio is 2.31, which is higher than the FMED Sharpe Ratio of 0.44. The chart below compares the historical Sharpe Ratios of JEPQ and FMED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

JEPQ vs. FMED - Drawdown Comparison

The maximum JEPQ drawdown since its inception was -20.07%, smaller than the maximum FMED drawdown of -21.84%. Use the drawdown chart below to compare losses from any high point for JEPQ and FMED.

Drawdown Indicators

	JEPQ	FMED	Difference
Max Drawdown Largest peak-to-trough decline	-20.07%	-21.84%	+1.77%
Max Drawdown (1Y) Largest decline over 1 year	-8.82%	-18.33%	+9.51%
Max Drawdown (3Y) Largest decline over 3 years	-20.07%	-21.84%	+1.77%
Current Drawdown Current decline from peak	0.00%	-10.64%	+10.64%
Average Drawdown Average peak-to-trough decline	-3.41%	-7.09%	+3.68%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.85%	8.27%	-6.42%

Volatility

JEPQ vs. FMED - Volatility Comparison

The current volatility for JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) is 5.42%, while Fidelity Disruptive Medicine ETF (FMED) has a volatility of 7.50%. This indicates that JEPQ experiences smaller price fluctuations and is considered to be less risky than FMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	JEPQ	FMED	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.42%	7.50%	-2.08%
Volatility (6M) Calculated over the trailing 6-month period	10.44%	15.01%	-4.57%
Volatility (1Y) Calculated over the trailing 1-year period	12.78%	19.37%	-6.59%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.76%	18.57%	-1.81%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.76%	18.57%	-1.81%

JEPQ vs. FMED - Expense Ratio Comparison

JEPQ has a 0.35% expense ratio, which is lower than FMED's 0.50% expense ratio.

Dividends

JEPQ vs. FMED - Dividend Comparison

JEPQ's dividend yield for the trailing twelve months is around 10.00%, while FMED has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022
FMED Fidelity Disruptive Medicine ETF	0.00%	0.00%	0.46%	0.00%	0.00%
JEPQ JPMorgan Nasdaq Equity Premium Income ETF	10.00%	10.53%	9.65%	10.03%	9.44%

Frequently Asked Questions

Can I hold both JEPQ and FMED in my portfolio?

JEPQ and FMED have a correlation of 0.49, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, JEPQ or FMED?

FMED has higher volatility (7.50%) compared to JEPQ (5.42%). In terms of maximum drawdown, JEPQ dropped -20.07% vs FMED's -21.84%.

Which ETF is better, JEPQ or FMED?

On 3-year performance, JEPQ leads with 20.72% vs 0.73% for FMED. On fees, JEPQ is cheaper at 0.35% per year. On volatility, JEPQ has been the lower-risk option at 5.42%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, JEPQ or FMED?

Over the 3-year period, JEPQ has performed better with a 20.72% return vs 0.73%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, JEPQ or FMED?

JEPQ is cheaper with a 0.35% expense ratio, compared with 0.50% for FMED.

Which ETF pays a higher dividend yield, JEPQ or FMED?

JEPQ has the higher dividend yield at 10.00%, compared with 0.00% for FMED.

What is the main difference between JEPQ and FMED?

JEPQ is categorized as Nasdaq-100, while FMED is Health & Biotech Equities. They also come from different issuers: JPMorgan and Fidelity. Their fees differ too: 0.35% for JEPQ and 0.50% for FMED.

Which has better risk-adjusted returns?

JEPQ currently has the higher Sharpe Ratio (2.31 vs 0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.